Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-TS-26-165: Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Closed Closed June 10, 2026 Opportunity RFA-TS-26-165 ☆ Save

This grant is closed. A newer notice from the same program is forecast: Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) (RFA-TS-27-018). Status: Expected deadline February 1, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2026.

• Award ceiling$500,000
• Total funding$4.5 million
• Expected awards3
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to any type of organization.

Additional Eligibility Information to be included in the NOFO.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Past Innovations in Applied Public Health Research awards averaged $557,604; this notice allows up to $500,000 per award.
• No cost sharing or match is required.

What the grant funds

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, RFA-TS-27-018, which is forecast.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.